TEVA stock lower as company eyes up to $3.6 billion to settle opioid claims - Reuters | Seeking Alpha
Drugmaker Teva looks to sell Medis business to help cut debt | Reuters
Teva stock plummets 18% after rough quarter in US generic drug market
Cipla, Aurobindo Pharma acquire products divested by Teva in US | Mint
Teva Pharm to lay off a quarter of workforce, suspends dividend
Teva lied about opioid role, New York says | Reuters
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,